Becton Dickinson To Settle UltiMed Antitrust Suit
Becton Dickinson & Co. will pay rival medical technology company UltiMed Inc. $750,000 to settle an antitrust suit accusing Becton Dickinson of barring competition in the market for home-use insulin syringes....To view the full article, register now.
Already a subscriber? Click here to view full article